Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STR-324 dose-finding study in postoperative pain
NL-OMON54385Phase 2Recruiting
- Sponsor
- Alaxia
- Start
- Feb 2021
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of STR-324 in postoperative pain (2 arms), sponsored by Alaxia. Primary endpoints: Change in pain intensity on Numerical Rating Scale, Responder status by pain reduction and 1 more. Started Feb 2021; status: recruiting.
02
Drugs
STR-324
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NL-OMON54385.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON54385.